IT Systems Manager, AI Administration
Salary: USD 125k–155k · Employer-posted
Celea Therapeutics is dedicated to advancing transformative treatments for people with serious respiratory diseases. Its lead program, deupirfenidone (LYT-100), is in Phase 3 development for idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases.
Follow Celea Therapeutics
Create an exact-company alert for on-site matches and optional daily email.
Salary: USD 125k–155k · Employer-posted
Salary: USD 130k–150k · Employer-posted